Pulmonx (LUNG) Share-based Compensation (2019 - 2025)
Pulmonx (LUNG) reported Share-based Compensation of $5.2 million for Q3 2025, up 638.0% year-over-year from $700000.0 in Q3 2024, and down 16.87% on a QoQ basis from $6.2 million in Q2 2025.
Pulmonx (LUNG) has 7 years of Share-based Compensation data on file, last reported at $5.2 million in Q3 2025.
- Quarterly Share-based Compensation rose 638.0% year-over-year to $5.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $22.5 million (up 77.69% YoY) and the FY2024 annual result came in at $23.0 million, up 3.86% from the prior year.
- Share-based Compensation slipped to $5.2 million in Q3 2025 per LUNG's latest filing, from $6.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.2 million in Q2 2025 and bottomed at $700000.0 in Q2 2024.
- The 5-year median for Share-based Compensation is $4.4 million (2022), against an average of $4.1 million.
- The widest annual swing landed in 2021, when Share-based Compensation surged 1354.09%; it then sank 88.34% in 2024.
- Tracing LUNG's Share-based Compensation over 5 years: stood at $3.0 million in 2021, then soared by 41.0% to $4.2 million in 2022, then surged by 31.81% to $5.6 million in 2023, then fell by 1.34% to $5.5 million in 2024, then fell by 6.46% to $5.2 million in 2025.
- Per Business Quant, the three latest LUNG Share-based Compensation figures stand at $5.2 million (Q3 2025), $6.2 million (Q2 2025), and $5.6 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.17 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 6.21 Mn |
| Jun 30, 2025 | 6.21 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Dec 31, 2024 | 5.52 Mn |
| Dec 31, 2024 | 5.52 Mn |
| Sep 30, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 5.67 Mn |
| Mar 31, 2024 | 5.67 Mn |
| Dec 31, 2023 | 5.60 Mn |
| Dec 31, 2023 | 5.60 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Mar 31, 2023 | 4.64 Mn |
| Mar 31, 2023 | 4.64 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Sep 30, 2022 | 4.30 Mn |
| Sep 30, 2022 | 4.30 Mn |
| Jun 30, 2022 | 4.38 Mn |
| Jun 30, 2022 | 4.38 Mn |
| Mar 31, 2022 | 3.51 Mn |
| Mar 31, 2022 | 3.51 Mn |
| Dec 31, 2021 | 3.01 Mn |
| Dec 31, 2021 | 3.01 Mn |
| Sep 30, 2021 | 2.94 Mn |
| Sep 30, 2021 | 2.94 Mn |
| Jun 30, 2021 | 2.31 Mn |
| Jun 30, 2021 | 2.31 Mn |
| Mar 31, 2021 | 2.27 Mn |
| Mar 31, 2021 | 2.27 Mn |
| Dec 31, 2020 | 2.31 Mn |
| Dec 31, 2020 | 2.31 Mn |
| Sep 30, 2020 | 518,000.00 |
| Sep 30, 2020 | 518,000.00 |
| Jun 30, 2020 | 159,000.00 |
| Jun 30, 2020 | 159,000.00 |
| Mar 31, 2020 | 209,000.00 |
| Mar 31, 2020 | 209,000.00 |
| Dec 31, 2019 | 167,000.00 |
| Dec 31, 2019 | 167,000.00 |